These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24440272)

  • 41. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor.
    Abbasalizadeh S; Larijani MR; Samadian A; Baharvand H
    Tissue Eng Part C Methods; 2012 Nov; 18(11):831-51. PubMed ID: 22559864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells.
    Totonchi M; Taei A; Seifinejad A; Tabebordbar M; Rassouli H; Farrokhi A; Gourabi H; Aghdami N; Hosseini-Salekdeh G; Baharvand H
    Int J Dev Biol; 2010; 54(5):877-86. PubMed ID: 19876814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
    Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
    PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemically Defined Neural Conversion of Human Pluripotent Stem Cells.
    Chen Y; Tristan CA; Mallanna SK; Ormanoglu P; Titus S; Simeonov A; Singeç I
    Methods Mol Biol; 2019; 1919():59-72. PubMed ID: 30656621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
    Rivera T; Zhao Y; Ni Y; Wang J
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A.
    Lach MS; Wroblewska JP; Augustyniak E; Kulcenty K; Suchorska WM
    Stem Cell Res; 2017 Apr; 20():34-37. PubMed ID: 28395738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
    Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
    Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells.
    Rajala K; Lindroos B; Hussein SM; Lappalainen RS; Pekkanen-Mattila M; Inzunza J; Rozell B; Miettinen S; Narkilahti S; Kerkelä E; Aalto-Setälä K; Otonkoski T; Suuronen R; Hovatta O; Skottman H
    PLoS One; 2010 Apr; 5(4):e10246. PubMed ID: 20419109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension.
    Elanzew A; Sommer A; Pusch-Klein A; Brüstle O; Haupt S
    Biotechnol J; 2015 Oct; 10(10):1589-99. PubMed ID: 26110829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of automated culture system for murine induced pluripotent stem cells.
    Koike H; Kubota K; Sekine K; Takebe T; Ouchi R; Zheng YW; Ueno Y; Tanigawa N; Taniguchi H
    BMC Biotechnol; 2012 Nov; 12():81. PubMed ID: 23127273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion.
    Hasegawa K; Yasuda SY; Teo JL; Nguyen C; McMillan M; Hsieh CL; Suemori H; Nakatsuji N; Yamamoto M; Miyabayashi T; Lutzko C; Pera MF; Kahn M
    Stem Cells Transl Med; 2012 Jan; 1(1):18-28. PubMed ID: 23197636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions.
    van Wilgenburg B; Browne C; Vowles J; Cowley SA
    PLoS One; 2013; 8(8):e71098. PubMed ID: 23951090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring.
    Dhingra A; Täger J; Bressan E; Rodriguez-Nieto S; Bedi MS; Bröer S; Sadikoglou E; Fernandes N; Castillo-Lizardo M; Rizzu P; Heutink P
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the characteristics of mesenchymal stem-like cells derived by integration-free induced pluripotent stem cells in different single-cell culture media under feeder-free conditions.
    Ueda M; Hashimoto Y; Honda Y; Baba S; Morita S
    Med Mol Morphol; 2019 Sep; 52(3):147-155. PubMed ID: 30446810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term serial cultivation of mouse induced pluripotent stem cells in serum-free and feeder-free defined medium.
    Yamasaki S; Nabeshima K; Sotomaru Y; Taguchi Y; Mukasa H; Furue MK; Sato JD; Okamoto T
    Int J Dev Biol; 2013; 57(9-10):715-24. PubMed ID: 24307297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defined Medium Conditions for the Induction and Expansion of Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
    Lidgerwood GE; Lim SY; Crombie DE; Ali R; Gill KP; Hernández D; Kie J; Conquest A; Waugh HS; Wong RC; Liang HH; Hewitt AW; Davidson KC; Pébay A
    Stem Cell Rev Rep; 2016 Apr; 12(2):179-88. PubMed ID: 26589197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large-Scale Production of Wholly Cellular Bioinks via the Optimization of Human Induced Pluripotent Stem Cell Aggregate Culture in Automated Bioreactors.
    Ho DLL; Lee S; Du J; Weiss JD; Tam T; Sinha S; Klinger D; Devine S; Hamfeldt A; Leng HT; Herrmann JE; He M; Fradkin LG; Tan TK; Standish D; Tomasello P; Traul D; Dianat N; Ladi R; Vicard Q; Katikireddy K; Skylar-Scott MA
    Adv Healthc Mater; 2022 Dec; 11(24):e2201138. PubMed ID: 36314397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.
    Chou BK; Gu H; Gao Y; Dowey SN; Wang Y; Shi J; Li Y; Ye Z; Cheng T; Cheng L
    Stem Cells Transl Med; 2015 Apr; 4(4):320-32. PubMed ID: 25742692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accelerated protocol for the differentiation of podocytes from human pluripotent stem cells.
    Bejoy J; Qian ES; Woodard LE
    STAR Protoc; 2021 Dec; 2(4):100898. PubMed ID: 34746862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.